In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: A new tool for oncology and radiotracer development

Journal of Nuclear Medicine

Volumn 54, Issue 10, 2013, Pages 1782-1788

  Warnock, Geoff ^a   Turtoi, Andrei ^a   Blomme, Arnaud ^a   Bretin, Florian ^a   Bahri, Mohamed Ali ^a   Lemaire, Christian ^a   Libert, Lionel Cyrille ^a   Seret, Alain E J J ^a   Luxen, André ^a   Castronovo, Vincenzo ^a   Plenevaux, Alain R E G ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

CAM model; Glioblastoma; Imaging

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUOROTYROSINE F 18; GLUCOSE; SODIUM FLUORIDE F 18; TRACER; TUMOR PROTEIN; UNCLASSIFIED DRUG; 2 FLUOROTYROSINE; 2-FLUOROTYROSINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORINE; SODIUM FLUORIDE; TYROSINE;

ARTICLE; BLOOD VESSEL; CANCER RESEARCH; CATHETERIZATION; CHORIOALLANTOIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG SCREENING; EMBRYO; FEASIBILITY STUDY; GLIOBLASTOMA; GLUCOSE METABOLISM; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VIVO STUDY; INCUBATION TIME; MEASUREMENT ACCURACY; NONHUMAN; PET SCANNER; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TUMOR VOLUME; ANIMAL; CAM MODEL; CHICKEN; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; DRUG DEVELOPMENT; IMAGING; METABOLISM; METHODOLOGY; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; TUMOR CELL LINE; ANALOGS AND DERIVATIVES; DIAGNOSTIC USE; PROCEDURES;

CAM MODEL; GLIOBLASTOMA; IMAGING;

ANIMALS; CELL LINE, TUMOR; CHICKENS; CHORIOALLANTOIC MEMBRANE; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; GLUCOSE; HUMANS; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; SODIUM FLUORIDE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; TYROSINE;

EID: 84891697464     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.117150     Document Type: Article

References (35)

1. Histed SN, Lindenberg ML, Mena E, Turkbey B, Choyke PL, Kurdziel KA. Review of functional/anatomical imaging in oncology. Nucl Med Commun. 2012;33:349-361.
2. 18F-FRGD2. J Nucl Med. 2006;47:113-121.
3. Hagedorn M, Javerzat S, Gilges D, et al. Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci USA. 2005;102:1643-1648.
4. Aldhous P, Coghlan A, Copley J. Animal experiments: where do you draw the line? Let the people speak. New Sci. 1999;162:26-31.
5. Durupt F, Koppers-Lalic D, Balme B, et al. The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses. Cancer Gene Ther. 2012;19:58-68.
6. Kim J, Yu W, Kovalski K, Ossowski L. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell. 1998;94:353-362.
7. Lugassy C, Kleinman HK, Engbring JA, et al. Pericyte-like location of GFPtagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. Am J Pathol. 2004;164:1191-1198.
8. Lugassy C, Vernon SE, Busam K, et al. Angiotropism of human melanoma: studies involving in transit and other cutaneous metastases and the chicken chorioallantoic membrane: implications for extravascular melanoma invasion and metastasis. Am J Dermatopathol. 2006;28:187-193.
9. Zijlstra A, Mellor R, Panzarella G, et al. A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res. 2002;62:7083-7092.
10. Kobayashi T, Koshida K, Endo Y, et al. A chick embryo model for metastatic human prostate cancer. Eur Urol. 1998;34:154-160.
11. Taizi M, Deutsch VR, Leitner A, Ohana A, Goldstein RS. A novel and rapid in vivo system for testing therapeutics on human leukemias. Exp Hematol. 2006;34:1698-1708.
12. Lamour V, LeMercier M, Lefranc F, et al. Selective osteopontin knockdown exerts antitumoral activity in a human glioblastoma model. Int J Cancer. 2010;126:1797-1805.
13. Saidi A, Hagedorn M, Allain N, et al. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer. 2009;125:1054-1064.
14. 18F) injection" in a GMP compliant facility. Ann Nucl Med. 2010;24:149-155.
15. 18F]FDG synthesis by alkaline hydrolysis on a low polarity solid phase support. J Labelled Comp Radiopharm. 2002;45:435-447.
16. 18F]fluoro-L-dopa. J Nucl Med. 2013;54:1154-1161.
17. Bahri MA, Plenevaux A, Warnock G, Luxen A, Seret A. NEMA NU4-2008 image quality performance report for the microPET focus 120 and for various transmission and reconstruction methods. J Nucl Med. 2009;50:1730-1738.
18. Kim JS, Lee JS, Im KC, et al. Performance measurement of the microPET focus 120 scanner. J Nucl Med. 2007;48:1527-1535.
19. Bahri MA, Warnock G, Plenevaux A, et al. Performance evaluation of the General Electric eXplore CT 120 micro-CT using the vmCT phantom. Nucl Instrum Meth A. 2011;648(suppl 1):S181-S185.
20. Bretin F, Bahri MA, Warnock G, Luxen A, Seret A, Plenevaux A. X-ray dose quantification for various scanning protocols with the GE eXplore 120 micro-CT. Proc IEEE NSS and MIC. 2012. http://ieeexplore.ieee.org/xpl/articleDetails.jsp? tp=&arnumber=6551866&queryText%3Dbretin+quantification. Accessed August 15, 2013.
21. Bahri MA, Bretin F, Warnock G, et al. Evaluation of the GE eXplore CT 120 micro-CT for various scanning protocols. Proc IEEE NSS and MIC. 2012;M21-18:3783-3785.
22. 18F-FDG PET with real-time arterial and imagederived input function in mice. J Nucl Med. 2013;54:132-138.
23. 18F- fluoride positron emission tomography. Mol Imaging Biol. 2012;14:688-698.
24. Badea CT, Athreya KK, Espinosa G, et al. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS ONE. 2012;7:e34496.
25. Boone JM, Velazquez O, Cherry SR. Small-animal X-ray dose from micro-CT. Mol Imaging. 2004;3:149-158.
26. Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol. 2000;27:643-646.
27. 18F-FDG PET studies in mice. J Nucl Med. 2006;47:999-1006.
28. Schmidt GS, Figueiredo EAP, Saatkamp MG, Bomm ER. Effect of storage period and egg weight on embryo development and incubation results. Rev Bras Cienc Avic. 2009;11:1-5.
29. Rasey JS, Koh WJ, Grierson JR, Grunbaum Z, Krohn KA. Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys. 1989;17:985-991.
30. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153-158.
31. Karathanasis E, Suryanarayanan S, Balusu SR, et al. Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography. Radiology. 2009;250:398-406.
32. Balaban E, Desco M, Vaquero JJ. Waking-like brain function in embryos. Curr Biol: CB. 2012;22:852-861.
33. Martin GS, Venuta S, Weber M, Rubin H. Temperature-dependent alterations in sugar transport in cells infected by a temperature-sensitive mutant of Rous sarcoma virus. Proc Natl Acad Sci USA. 1971;68:2739-2741.
34. Venuta S, Rubin H. Sugar transport in normal and Rous sarcoma virustransformed chick-embryo fibroblasts. Proc Natl Acad Sci USA. 1973;70:653-657.
35. 201Tl in normal and transformed thyroid cell lines. J Nucl Med Allied Sci. 1979;23:163-166.